{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:51:23Z","timestamp":1790394683426,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":1073,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000019","name":"National Hemophilia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL126810"],"award-info":[{"award-number":["R01HL126810"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24HL114474"],"award-info":[{"award-number":["R24HL114474"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL102035"],"award-info":[{"award-number":["R01HL102035"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01HL081588"],"award-info":[{"award-number":["P01HL081588"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL112614"],"award-info":[{"award-number":["R01HL112614"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL139847"],"award-info":[{"award-number":["R01HL139847"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1002\/rth2.12280","type":"journal-article","created":{"date-parts":[[2019,12,29]],"date-time":"2019-12-29T23:32:16Z","timestamp":1577662336000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A rat model of severe VWD by elimination of the VWF gene using CRISPR\/Cas9"],"prefix":"10.1016","volume":"4","author":[{"given":"Jessica","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica H.","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Haberichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scot A.","family":"Fahs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy G.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron M.","family":"Geurts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12280_bb0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence\u2010based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1002\/rth2.12280_bb0015","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2141.2000.02507.x","article-title":"Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease","volume":"111","author":"Lak","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1002\/rth2.12280_bb0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1002\/rth2.12280_bb0025","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1016\/S0021-9258(19)76501-6","article-title":"Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III","volume":"262","author":"Pareti","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1002\/rth2.12280_bb0030","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood-2014-11-610824","article-title":"RG and others. Crucial role for the VWF A1 domain in binding to type IV collagen","volume":"125","author":"Flood","year":"2015","journal-title":"Blood"},{"key":"10.1002\/rth2.12280_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.V61.1.99.99","article-title":"Studies with a murine monoclonal antibody that abolishes ristocetin\u2010induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor","volume":"61","author":"Coller","year":"1983","journal-title":"Blood"},{"key":"10.1002\/rth2.12280_bb0040","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s000180050487","article-title":"Insights from von Willebrand disease animal models","volume":"56","author":"Denis","year":"1999","journal-title":"Cell Mol Life Sci"},{"issue":"Suppl 3","key":"10.1002\/rth2.12280_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2516.1998.0040s3053.x","article-title":"Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease","volume":"4","author":"Schwarz","year":"1998","journal-title":"Haemophilia"},{"key":"10.1002\/rth2.12280_bb0050","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.ATV.15.6.793","article-title":"Thrombotic thrombocytopenia induced in dogs and pigs. The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura","volume":"15","author":"Sanders","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1002\/rth2.12280_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/01.ATV.7.1.47","article-title":"Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease","volume":"7","author":"Wu","year":"1987","journal-title":"Arteriosclerosis"},{"key":"10.1002\/rth2.12280_bb0060","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.95.16.9524","article-title":"A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis","volume":"95","author":"Denis","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/rth2.12280_bb0065","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR\u2010Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1002\/rth2.12280_bb0070","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1002\/rth2.12280_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI110946","article-title":"Platelets have more than one binding site for von Willebrand factor","volume":"72","author":"Rugger","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1002\/rth2.12280_bb0080","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1373\/clinchem.2012.199000","article-title":"Collagen binding provides a sensitive screen for variant von Willebrand disease","volume":"59","author":"Flood","year":"2013","journal-title":"Clin Chem"},{"key":"10.1002\/rth2.12280_bb0085","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI1250","article-title":"Intracellular trafficking of factor VIII to von Willebrand factor storage granules","volume":"101","author":"Rosenberg","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1002\/rth2.12280_bb0090","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/jth.12635","article-title":"A novel F8\u2013\/\u2013 rat as a translational model of human hemophilia A","volume":"12","author":"Nielsen","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12280_bb0095","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2141.1996.d01-1860.x","article-title":"AR and others. Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups","volume":"94","author":"Menache","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1002\/rth2.12280_bb0100","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Pavlova BG and others. Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease","volume":"126","author":"Gill","year":"2015","journal-title":"Blood"},{"key":"10.1002\/rth2.12280_bb0105","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2516.2011.02735.x","article-title":"Intravascular recovery of VWF and FVIII following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice","volume":"18","author":"Shi","year":"2012","journal-title":"Haemophilia"},{"key":"10.1002\/rth2.12280_bb0110","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI112974","article-title":"Gene deletions correlate with the development of alloantibodies in von Willebrand disease","volume":"79","author":"Shelton\u2010Inloes","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1002\/rth2.12280_bb0115","first-page":"71","article-title":"Rat genome databases, repositories, and tools","volume":"2018","author":"Laulederkind","year":"2019","journal-title":"Methods Mol Biol"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frth2.12280","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12280","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12280","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922019537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922019537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:19:57Z","timestamp":1762863597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922019537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2475037922019537"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12280","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rat model of severe VWD by elimination of the VWF gene using CRISPR\/Cas9","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}